Revance Therapeutics, Inc. reports

Company location: Nashville, TN
Fiscal year end: 31 December

Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 576-600 of 946 matching filings.

Per page

25

Current page

24

4

FORM 4

Filing date: 03 Jul 2018
Reporting date: 29 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 22 Jun 2018
Reporting date: 20 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 22 Jun 2018
Reporting date: 20 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 22 Jun 2018
Reporting date: 20 Jun 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-36297

CT ORDER filing

Filing date: 11 Jun 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 29 May 2018
Reporting date: 27 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 24 May 2018
Reporting date: 22 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 11 May 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36297

10-Q

Filing date: 09 May 2018
Reporting date: 31 Mar 2018
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 08 May 2018
Reporting date: 08 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 19 Apr 2018
Reporting date: 19 Apr 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88023

SEC SCHEDULE 13G

Filing date: 10 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88023

SC 13G/A

Filing date: 09 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Mar 2018
Reporting date: 21 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Mar 2018
Reporting date: 22 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36297

DEF 14A

Filing date: 20 Mar 2018
Reporting date: 10 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Mar 2018
Reporting date: 16 Mar 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .